
Episode 20: Baxter
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
Send us a text
Baxter may not always grab the biotech headlines, but its impact on modern healthcare is impossible to ignore. From the first commercially prepared IV solutions in the 1930s to pioneering dialysis fluids, blood systems, recombinant hemophilia therapies, and parenteral nutrition, Baxter has consistently solved medicine’s “unsexy but essential” problems.
In this episode, we dive into the company’s origins, explore the backstories of its most important innovations, and trace how it spun off biotech powerhouse Baxalta, later snapped up by Shire and Takeda. Along the way, we highlight the people who left their mark and extract key lessons from Baxter’s journey through growth, crisis, and reinvention.
Whether you’re a biotech enthusiast, a healthcare professional, or just curious about the companies that quietly keep hospitals running, this episode sheds light on why Baxter deserves your attention.
🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
Hashtags:
#BiotechUnleashed #PetriDishPerspectives #Baxter #BiotechHistory #HealthcareInnovation #Biopharma #LifeSciences #DrugDiscovery #MedicalDevices #PharmaIndustry
Support the show
© 2025 Petri Dish Perspectives LLC. All rights reserved.